Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trial

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1748-717X
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trial ; volume:12 ; number:1 ; day:22 ; month:9 ; year:2017 ; pages:1-8 ; date:12.2017
Radiation oncology ; 12, Heft 1 (22.9.2017), 1-8, 12.2017

Schlagwort
Krebs
Onkologie

Urheber
De Wolf, Katrien
Beteiligte Personen und Organisationen
Rottey, Sylvie
Vermaelen, Karim
Decaestecker, Karel
Sundahl, Nora
De Lobel, Lizzy
Goetghebeur, Els
De Meerleer, Gert
Lumen, Nicolaas
Fonteyne, Valerie
De Maeseneer, Daan
Ost, Piet
SpringerLink (Online service)

DOI
10.1186/s13014-017-0893-x
URN
urn:nbn:de:1111-2017112012427
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:26 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • De Wolf, Katrien
  • Rottey, Sylvie
  • Vermaelen, Karim
  • Decaestecker, Karel
  • Sundahl, Nora
  • De Lobel, Lizzy
  • Goetghebeur, Els
  • De Meerleer, Gert
  • Lumen, Nicolaas
  • Fonteyne, Valerie
  • De Maeseneer, Daan
  • Ost, Piet
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Radiation treatment planning with embedded dose escalation

Radiation treatment planning with embedded dose escalation

Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors

Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors

Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?

Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?

Dose escalation of a curcuminoid formulation

Dose escalation of a curcuminoid formulation

Radiation dose escalation for loco-regional recurrence of breast cancer after mastectomy

Radiation dose escalation for loco-regional recurrence of breast cancer after mastectomy

Radiation dose quantities

zweidimensionales bewegtes Bild

Radiation dose quantities

A Phase I, Dose-Escalation Trial of Pazopanib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A UNICANCER Study

A Phase I, Dose-Escalation Trial of Pazopanib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A UNICANCER Study

Dose escalation can maximize therapeutic potential of sunitinib in patients with metastatic renal cell carcinoma

Dose escalation can maximize therapeutic potential of sunitinib in patients with metastatic renal cell carcinoma

Radiation : doses, effects, risk

Radiation : doses, effects, risk

Incoherent dose-escalation in phase I trials using the escalation with overdose control approach

Incoherent dose-escalation in phase I trials using the escalation with overdose control approach

Dose escalation of radiation therapy with or without induction chemotherapy for unresectable locally advanced pancreatic cancer

Dose escalation of radiation therapy with or without induction chemotherapy for unresectable locally advanced pancreatic cancer

Dose escalation with stereotactic body radiation therapy boost for locally advanced non small cell lung cancer

Dose escalation with stereotactic body radiation therapy boost for locally advanced non small cell lung cancer

Verbundene Objekte